PanGenex is a publicly traded company (PINK SHEETS: PGXC) and pursues business opportunities in the nutraceutical and cardiovascular health industries. The Company seeks to develop and market novel, patented or patent pending, condition specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products. Each product is scientifically formulated to address specific health conditions throughout the population. The products are marketed through healthcare practitioners throughout the U.S. In addition, the Company markets direct to consumers over the internet.